Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8396)	1/21/1999 9:27:00 AM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Gne has a large news release out today which has a small mention of a company called xoma. " Made $2 million milestone payment to partner XOMA Ltd. for its successful completion of Phase II clinical trials of Genentech's anti-CD11a antibody (hu1124) for the potential treatment of psoriasis " I myself am wondering how Bill C. would define the word successful. Is it successful as in completion. Or is is successful as in results. Or I guess it could also depend on the actual MOMENT the word was used. All IMO. All disclaimers apply.